#NICE #NHS #vitiligo #vitiligotreatment #NICEnews #skinlighteningdisorder #NICEapprovedtreatment #Reimbursement #Incyte #JAKinhibitorcream #Opzelura #ruxolitinib #facialvitiligo #JAKsignallingpathway #TheVitiligoSociety #oralJAKinhibitors #skindisorder #dermatology
zurl.co/dZyqZ
zurl.co/dZyqZ
Joy as NICE changes tack on first NHS vitiligo treatment
NHS patients in England with vitiligo will soon be able to access Incyte's Opzelura, the first drug shown to reverse the skin-lightening disorder.
pharmaphorum.com
March 2, 2026 at 10:57 AM